Congestive Heart Failure

Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book Congestive Heart Failure by J. Morganroth, E. Neil Moore, Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: J. Morganroth, E. Neil Moore ISBN: 9781461320777
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author: J. Morganroth, E. Neil Moore
ISBN: 9781461320777
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend beyond the use of bed rest, sodium restriction, digitalis and diuretics. These include vasodilators of a variety of types including the angiotensin conventional enzyme (ACE) inhibitors. Also, many new inotropes are under active investigation both in oral and intravenous forms. In March of 1984 a survey of over 5000 physicians was performed under the auspices of the American Heart Association (reported in: JAOC 8:966, 1986). That survey showed that there was no universally accepted defini tion for congestive heart fai lure and that a wide spectrum of diagnostic cri teria for this common condi tion existed even among academic cardiologists. There was no clear standard as to even the mos t bas ic treatment of conges t i ve heart fai lure. For example, exercise restriction was recommended by 19% of physicians, 31% recommended no change in activity, and 50% either light exercise or an exercise conditioning program.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend beyond the use of bed rest, sodium restriction, digitalis and diuretics. These include vasodilators of a variety of types including the angiotensin conventional enzyme (ACE) inhibitors. Also, many new inotropes are under active investigation both in oral and intravenous forms. In March of 1984 a survey of over 5000 physicians was performed under the auspices of the American Heart Association (reported in: JAOC 8:966, 1986). That survey showed that there was no universally accepted defini tion for congestive heart fai lure and that a wide spectrum of diagnostic cri teria for this common condi tion existed even among academic cardiologists. There was no clear standard as to even the mos t bas ic treatment of conges t i ve heart fai lure. For example, exercise restriction was recommended by 19% of physicians, 31% recommended no change in activity, and 50% either light exercise or an exercise conditioning program.

More books from Springer US

Cover of the book Highly Linear Integrated Wideband Amplifiers by J. Morganroth, E. Neil Moore
Cover of the book Ischemic Preconditioning: The Concept of Endogenous Cardioprotection by J. Morganroth, E. Neil Moore
Cover of the book Supervisory Control of Discrete Event Systems Using Petri Nets by J. Morganroth, E. Neil Moore
Cover of the book Phantom Pain by J. Morganroth, E. Neil Moore
Cover of the book Valuation, Hedging and Speculation in Competitive Electricity Markets by J. Morganroth, E. Neil Moore
Cover of the book Archaeologies of Remembrance by J. Morganroth, E. Neil Moore
Cover of the book Methods in Mammary Gland Biology and Breast Cancer Research by J. Morganroth, E. Neil Moore
Cover of the book The Art and Science of Inventing by J. Morganroth, E. Neil Moore
Cover of the book Osteoporosis: Genetics, Prevention and Treatment by J. Morganroth, E. Neil Moore
Cover of the book Public Places and Spaces by J. Morganroth, E. Neil Moore
Cover of the book Cancer in Childhood by J. Morganroth, E. Neil Moore
Cover of the book Current Topics in Primate Vocal Communication by J. Morganroth, E. Neil Moore
Cover of the book Feeding the Brain by J. Morganroth, E. Neil Moore
Cover of the book Cytokines and Growth Factors in Blood Transfusion by J. Morganroth, E. Neil Moore
Cover of the book Biodeterioration Research 1 by J. Morganroth, E. Neil Moore
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy